IL305534A - device for the treatment of anaphylaxis - Google Patents

device for the treatment of anaphylaxis

Info

Publication number
IL305534A
IL305534A IL305534A IL30553423A IL305534A IL 305534 A IL305534 A IL 305534A IL 305534 A IL305534 A IL 305534A IL 30553423 A IL30553423 A IL 30553423A IL 305534 A IL305534 A IL 305534A
Authority
IL
Israel
Prior art keywords
epinephrine
metered dose
dose inhaler
formulation
pressurized metered
Prior art date
Application number
IL305534A
Other languages
English (en)
Hebrew (he)
Original Assignee
1232176 B C Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 1232176 B C Ltd filed Critical 1232176 B C Ltd
Publication of IL305534A publication Critical patent/IL305534A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
    • A61M11/001—Particle size control
    • A61M11/003—Particle size control by passing the aerosol trough sieves or filters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0065—Inhalators with dosage or measuring devices
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/009—Inhalators using medicine packages with incorporated spraying means, e.g. aerosol cans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C19/00—Acyclic saturated compounds containing halogen atoms
    • C07C19/08—Acyclic saturated compounds containing halogen atoms containing fluorine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2209/00—Ancillary equipment
    • A61M2209/02—Equipment for testing the apparatus

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Anesthesiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Otolaryngology (AREA)
  • Emergency Medicine (AREA)
  • Biophysics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dispersion Chemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Immunology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Processing Of Meat And Fish (AREA)
  • Surgical Instruments (AREA)
  • Non-Portable Lighting Devices Or Systems Thereof (AREA)
IL305534A 2021-03-23 2022-03-23 device for the treatment of anaphylaxis IL305534A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202163165102P 2021-03-23 2021-03-23
PCT/US2022/021612 WO2022204328A1 (en) 2021-03-23 2022-03-23 Device for treating anaphylaxis

Publications (1)

Publication Number Publication Date
IL305534A true IL305534A (en) 2023-10-01

Family

ID=81307871

Family Applications (1)

Application Number Title Priority Date Filing Date
IL305534A IL305534A (en) 2021-03-23 2022-03-23 device for the treatment of anaphylaxis

Country Status (20)

Country Link
US (1) US20220331237A1 (cg-RX-API-DMAC7.html)
EP (2) EP4188332B1 (cg-RX-API-DMAC7.html)
JP (2) JP2024515446A (cg-RX-API-DMAC7.html)
KR (1) KR20230165764A (cg-RX-API-DMAC7.html)
CN (1) CN117083054A (cg-RX-API-DMAC7.html)
AU (1) AU2022245300B2 (cg-RX-API-DMAC7.html)
BR (1) BR112023019156A2 (cg-RX-API-DMAC7.html)
CA (1) CA3212189A1 (cg-RX-API-DMAC7.html)
DK (1) DK4188332T3 (cg-RX-API-DMAC7.html)
ES (2) ES3025005T3 (cg-RX-API-DMAC7.html)
FI (1) FI4188332T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20250566T1 (cg-RX-API-DMAC7.html)
HU (1) HUE071185T2 (cg-RX-API-DMAC7.html)
IL (1) IL305534A (cg-RX-API-DMAC7.html)
LT (1) LT4188332T (cg-RX-API-DMAC7.html)
PL (1) PL4188332T3 (cg-RX-API-DMAC7.html)
PT (1) PT4188332T (cg-RX-API-DMAC7.html)
RS (1) RS66787B1 (cg-RX-API-DMAC7.html)
SI (1) SI4188332T1 (cg-RX-API-DMAC7.html)
WO (1) WO2022204328A1 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12514995B2 (en) * 2021-02-15 2026-01-06 Glenmark Pharmaceuticals Limited Metered dose inhalers of fluticasone or an ester thereof
WO2025072756A1 (en) * 2023-09-28 2025-04-03 Kokua Pharma Inc. Device, methods, and uses for treating acute allergic reactions
WO2025170986A1 (en) * 2024-02-06 2025-08-14 Kindeva Drug Delivery L.P. Drug delivery device
US20260007598A1 (en) * 2024-07-05 2026-01-08 Honeywell International Inc. Compositions, devices and methods for respritory delivery of active pharmaceutical ingredients
US12496272B1 (en) * 2024-07-31 2025-12-16 Amphastar Pharmaceuticals, Inc. Stable epinephrine suspension formulation for inhalation with HFO propellant

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9324250D0 (en) * 1993-11-25 1994-01-12 Minnesota Mining & Mfg Inhaler
EP1321159A1 (en) 2001-12-21 2003-06-25 CHIESI FARMACEUTICI S.p.A. Pressurized metered dose inhaler (pMDI) actuators with laser drilled orifices
EP1340492A1 (en) * 2002-03-01 2003-09-03 CHIESI FARMACEUTICI S.p.A. Aerosol formulations for pulmonary administration of medicaments having systemic effects
EP1531794B1 (en) * 2002-06-28 2017-05-10 Civitas Therapeutics, Inc. Inhalable epinephrine
AU2004249166B2 (en) * 2003-06-13 2008-10-09 Alkermes, Inc. Low dose pharmaceutical powders for inhalation
WO2006101882A2 (en) * 2005-03-16 2006-09-28 Honeywell International Inc. Medicament delivery formulations, devices and methods
US8367734B1 (en) * 2005-08-11 2013-02-05 Amphastar Pharmaceuticals Inc. Stable epinephrine suspension formulation with high inhalation delivery efficiency
US8268347B1 (en) * 2006-10-24 2012-09-18 Aradigm Corporation Dual action, inhaled formulations providing both an immediate and sustained release profile
GB0801876D0 (en) * 2008-02-01 2008-03-12 Vectura Group Plc Suspension formulations
SI2627386T1 (sl) * 2010-10-12 2015-10-30 Ivax Pharmaceuticals Ireland Nosna pršilna naprava
US20120204871A1 (en) * 2011-02-10 2012-08-16 Julio Cesar Vega Stable, non-corrosive formulations for pressurized metered dose inhalers
WO2014033057A1 (en) * 2012-08-29 2014-03-06 Chiesi Farmaceutici S.P.A. Aerosol inhalation device
US10039710B2 (en) * 2015-09-18 2018-08-07 Insys Development Company, Inc. Epinephrine spray formulations
US9717683B1 (en) * 2016-06-29 2017-08-01 Ep Pharma, Llc Low-temperature inhalation administration of cannabinoid entities
ES2791775B2 (es) * 2018-02-06 2023-01-20 Aegis Therapeutics Llc Formulaciones de epinefrina intranasal y metodos para el tratamiento de enfermedades
WO2019182745A1 (en) * 2018-03-19 2019-09-26 Bryn Pharma, LLC Epinephrine spray formulations

Also Published As

Publication number Publication date
KR20230165764A (ko) 2023-12-05
JP2024515446A (ja) 2024-04-10
EP4188332A1 (en) 2023-06-07
CN117083054A (zh) 2023-11-17
EP4188332B1 (en) 2025-02-12
ES3025005T3 (en) 2025-06-05
RS66787B1 (sr) 2025-06-30
EP4545122C0 (en) 2026-07-15
AU2022245300A1 (en) 2023-09-14
CA3212189A1 (en) 2022-09-29
PL4188332T3 (pl) 2025-11-24
LT4188332T (lt) 2025-05-12
EP4545122A2 (en) 2025-04-30
WO2022204328A1 (en) 2022-09-29
SI4188332T1 (sl) 2025-07-31
FI4188332T3 (fi) 2025-05-06
HUE071185T2 (hu) 2025-08-28
JP2026094267A (ja) 2026-06-09
HRP20250566T1 (hr) 2025-06-20
ES3076082T3 (en) 2026-08-11
EP4545122A3 (en) 2025-05-07
DK4188332T3 (da) 2025-05-05
US20220331237A1 (en) 2022-10-20
PT4188332T (pt) 2025-04-17
BR112023019156A2 (pt) 2023-10-17
AU2022245300B2 (en) 2026-04-02
EP4545122B1 (en) 2026-07-15

Similar Documents

Publication Publication Date Title
EP4188332B1 (en) Device for treating anaphylaxis
AU2003222753B2 (en) Formoterol superfine formulation
JP2019203032A (ja) 経肺投与によって心疾患を治療するための単位用量、エアロゾル、キット、および方法
US20060018840A1 (en) Aerosolizable formulation comprising nicotine
JP7286319B2 (ja) エラスターゼ阻害活性を有するベータヘアピンペプチド模倣体及びそのエアロゾル剤形
IL262720B1 (en) Terfostinil in dry powder form for the treatment of pulmonary hypertension
CN103052378A (zh) 包含磷酸二酯酶抑制剂的药物制剂
IL262087A (en) Orally inhaled and nasal benzodiazepines
CA2633099C (en) Treatment of respiratory diseases
HK40087057A (en) Device for treating anaphylaxis
HK40087057B (en) Device for treating anaphylaxis
WO2025072756A1 (en) Device, methods, and uses for treating acute allergic reactions
HK40102631A (en) Device for treating anaphylaxis
IL323261A (en) Spray-dried treprostinil formulation
US20250352530A1 (en) Method and composition for treating lung diseases
WO2026064480A1 (en) Method and composition for treating lung diseases
KR20180065223A (ko) 천식의 치료 또는 완화용 약학 조성물
Collingwood et al. Optimizing drugs for local delivery
Alouache Novel phospholipid-based pressurised metered dose inhaler formulations